GCC Intravenous Solutions Market Estimated to Exceed US$ 997.8 Million By 2028 | CAGR of 5.9%

Published February 8, 2023

According to IMARC Group latest report titled “GCC Intravenous Solutions Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on Intravenous Solutions Industry in GCC. The report also includes competitor and regional analysis, and contemporary advancements in the market. The GCC intravenous solutions market size reached US$ 701.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 997.8 Million by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.

Intravenous solutions represent chemically prepared fluids consisting of various nutrients and medications, including vitamins, carbohydrates, salts, amino acids, electrolytes, and minerals. They are available in partial parenteral nutrition and total parenteral nutrition variants. Intravenous solutions are administered in the body through venous circulation and prove highly effective in providing nutrients to patients suffering from diabetes, cancer, immune deficiencies, cardiovascular ailments, and other related illnesses. They are mostly employed in intravenous (IV) therapy for replacing electrolyte losses, administering blood products and drugs, and supplying essential nutrients to the intravascular fluid compartment. Consequently, intravenous solutions find extensive applications in hospitals, clinics, and other healthcare establishments across GCC.

Get a Free Sample Copy of this Report: https://www.imarcgroup.com/gcc-intravenous-solutions-market/requestsample

Market Trends:

The growing prevalence of gastrointestinal disorders, diabetes, AIDS, and obesity and the elevating demand for IV therapies that offer rapid onset of drug effects as compared to other drug delivery systems are primarily driving the GCC intravenous solutions market. In addition to this, the launch of several policies by government bodies aimed at improving healthcare facilities is also positively influencing the market across the country. Apart from this, the development of new products for respective diseases and the treatment of chronic dehydration that can cause irritability, fatigue, memory problems, and other medical conditions is further stimulating the market growth. In line with this, the introduction of easy-to-use, portable products, which can be used as drips at home, is acting as another significant growth-inducing factor. Moreover, the increasing product usage to treat migraines and improve skin conditions and the escalating participation of individuals in physical activities, on account of the rising health consciousness, are expected to propel the GCC intravenous solutions market in the coming years.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/gcc-intravenous-solutions-market

GCC Intravenous Solutions Market Segmentation:

Our report has categorized the market based on country, type and nutrients.

Breakup by Type:

  • Partial Parenteral Nutrition
  • Total Parenteral Nutrition

Breakup by Nutrients:

  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids

Breakup by Country:

  • Saudi Arabia
  • UAE
  • Qatar
  • Oman
  • Oman
  • Bahrain

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Browse Other Reports:






About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800